Emerging Markets Pneumococcal Vaccines Medical and Scientific Affairs Lead

This position will assume a leadership role within the Emerging Market (EM) pneumococcal vaccines asset. The position will support medical affairs activities for EM with primary responsibility as the lead medical and scientific expert within the EM pneumococcal asset for the current (PCV13) and next generation (PCV20) pneumococcal conjugate vaccines. The position will be Responsible for the adaptation and implementation of the global medical strategy, this role will work very close with global team and get alignment on medical position to integrate a coherent strategy to sustain PCV 13 and to successfully launch and positioning PCV20 among EM. This will be achieved by cross-functional integration with different areas of pneumococcal vaccines (vaccine research and development, health outcomes, commercial, regulatory, safety, public affairs) at the global and local levels; coordinating work and strategies where appropriate with KOLs and external scientists; conducting and publishing results of high quality scientific studies of relevance to PCV goals; and functioning as a deputy to the EM medical lead for pneumococcal vaccines.

ROLE RESPONSIBILITIES

• Accountable for ensuring integration of scientific information (epidemiology, carriage, disease burden, public health value, etc.) in the pneumococcal asset as an integral member.
  
• Act as an expert on pneumococcal vaccines and pneumococcal science, within and outside of Pfizer
  
• Contribute to developing a strategy on publications, scientific congresses, and advisory boards each year to support scientific data related to pneumococcal vaccines.
  
• Identify, establish, and maintain relationships with eGlocal external partners that can inform on scientific issues of relevance to pneumococcal vaccine policies and decision-making
  
• Join the Glocal workstreams
  
• Lead the scientific dialogue and positioning of PCV and pneumococcal science via various avenues, including but not limited to:
  
• The development and execution of medical advisory boards in accordance with Pfizer policies and procedures.
  
• Working with internal and external experts to publish data in peer-reviewed manuscripts, including taking the lead for writing the first draft of these manuscripts
  
• Working with internal and external experts to develop abstracts and present data for scientific congresses, including taking the lead for writing and presenting
  
• Take responsibility for mandatory periodic regulatory/safety reporting (e.g., PSUR/DSUR/PBRER, WHO PVQAR)
  
• Provide credible and accurate scientific data demonstrating the value of our PCV products and differentiating them from our competitors to support country level tendering processes
  
• Assist with competitive intelligence for pneumococcal vaccines, including gathering and communicating findings
  
• Develop and update slide compendiums for medical-to-medical as well as internal use for the science related to pneumococcal disease and vaccination
  
• Oversee gathering and integrating published scientific data necessary for developing pneumococcal vaccine product labels
  
• Review external study proposals as member of the Epidemiology Sub-committee (ESC) and Medical Scientific Committee
  
• Contribute as a member of the Pneumococcal Vaccine Leadership Team
  

QUALIFICATIONS

• MD with relevant degree in a field such as epidemiology or public health;
  

• At least 10 years of working experience in medical field and/or in public health and a minimal 7 years of experience in vaccine-related or vaccine-preventable disease related medical/scientific activities including research, clinical development, epidemiological, and immunization programs. experience in pneumococcal disease and pneumococcal vaccines is desirable.
  

• Proven ability to interact with senior KOLs and Government officials dealing with immunization programs/vaccine policy and vaccine recommendations
  
• Demonstrated experience effectively leading and collaborating with matrixed teams
  
• Established track record of values and compliance leadership including across diverse cultures and geographies
  
• Documented ability to take a vaccine or vaccine-preventable disease project from start to end including conception, design, protocol, analytic plan, implementation, analysis, and reporting and interpretation of results
  
• Able to review, evaluate, interpret, and present complex data; understand information on emerging safety and efficacy profile of pneumococcal vaccines
  
• Understand the critical data elements related to assessing the public health value of pneumococcal vaccines, ability to oversee or conduct public health analyses of vaccine impact, and ability to interpret data and data limitations for both Pfizer and competitor pneumococcal vaccines
  
• Excellent verbal and written communication skills including scientific writing skills
  
• Strong work ethic and history of delivering project within stated timelines.
  
• Fluent in English writing, reading, speaking; multiple languages a plus (particularly Spanish, French, or mandarin) but not required
  
• Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact."
  

NON-STANDARD WORK SCHEDULE, TRAVEL OR ENVIRONMENT REQUIREMENTS

flexibility to travel when applied

Last Date to Apply for Job: January 22, 2021

Additional Location Information: Collegeville PA is preferred location however, open to candidates working from any site or remotely (globally)

Eligible for Employee Referral Bonus

#LI-PFE

Sunshine Act

Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider's name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.

EEO & Employment Eligibility

Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.

Medical

#LI-PFE